The global home healthcare market is projected to grow from $504.8 billion in 2026 to $1,015.8 billion by 2033, with a compound annual growth rate (CAGR) of 10.5%. This rapid expansion is driven by the rising demand for telemedicine and AI-powered healthcare solutions, primarily due to an aging global population and increasing healthcare costs. The Medical – Outpatient and Home Healthcare industry ranks #52 among nearly 250 Zacks industries, indicating positive near-term prospects.
Key players in the sector, including DaVita Inc. (DVA), LifeStance Health Group, Inc. (LFST), Option Care Health, Inc. (OPCH), and Aveanna Healthcare Holdings Inc. (AVAH), are positioned to benefit from these trends. For instance, DaVita anticipates a revenue growth of 4.7% and a 35.2% increase in earnings for 2026. Meanwhile, LifeStance projects revenue growth of 19.7% with earnings surging by 700% during the same period.
The industry’s shift towards value-based care models, technology adoption, and growing consumer preference for home-based services are critical factors supporting its growth, despite challenges such as staffing shortages and elevated operating costs.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
